Fluticasone furoate, vilanterol 50/25mcg, 100/25mcg, 200/25mcg; per inh; dry pwd for oral inh. Fluticasone furoate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity. The ...

Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US ... in a single inhaler, the Ellipta. Sales of the drug are starting to pick up since its ...

Meanwhile GSK's lead inhalers include Trelegy Ellipta, projected to bring $3.3bn in 2024 sales, followed by Relvar/Breo Ellipta and Seretide/Advair GlobalData is the parent company of Medical ...

The FDA has approved an expanded label for GlaxoSmithKline’s new Trelegy Ellipta ... ageing Advair inhaler, still a mainstay of GSK's respiratory portfolio, is threatened by generic competition ...